Skip to main content

Table 4 DCM cases, comparison between those who are alive and dead

From: The outcome of genetic and non-genetic pediatric cardiomyopathies

  

Alive

Died

Total

P-value

Odds ratio

Relative Risk

Gender

Male

56

24

80

0.568

1

1

Female

56

24

80

Mode of presentation

Heart failure

81

37

118

0.038

  

Cardiogenic shock

18

11

29

Asymptomatic

13

0

13

Primary or secondary

Primary

57

19

76

0.127

0.63

0.72

Secondary

55

29

84

Syndromic

Yes

9

5

14

0.415

1.33

1.21

No

103

43

146

Primary or secondary

Primary

53

19

4

0.483

0.62

0.72

Secondary

50

29

5

Suspected viral illness

Yes

22

2

24

0.008

0.18

0.25

No

90

46

136

LV noncompaction

Yes

84

46

130

0.001

7.67

5.31

No

28

2

30

Consanguineous parents

Yes

32

26

58

0.002

2.95

2.08

No

80

22

102

F/H of CMP

Yes

9

12

21

0.005

3.81

2.21

No

103

36

139

Genetic study

Positive/Abnormal

17

3

20

0.012

  

Negative/Normal

35

6

41

Pending

9

21

30

Normal

51

18

69

Age of presentation

6 months or Less

40

22

62

0.152

1.52

1.34

More than 6 months

72

26

98

Ejection fraction at presentation

20% or Less

10

25

35

 < 0.001

11.09

3.88

More than 20%

102

23

125

Admission on first presentation

Yes

78

44

122

0.002

4.79

3.43

No

34

4

38

ICU admission

Yes

51

29

5

0.045

2.27

1.81

No

40

10

0

IVIg administration

Yes

35

9

44

0.074

0.51

0.61

No

77

39

116

ICU admission

Yes

57

32

89

0.047

1.93

1.6

No

55

16

71

Ventilation

Yes

74

21

95

0.007

0.4

0.53

No

38

27

65

Inotropes

Yes

70

21

91

0.022

0.47

0.59

No

42

27

69

Carvidolol

Yes

10

8

18

0.127

2.04

1.58

No

102

40

142

Digoxin

Yes

39

16

55

0.503

1.22

1.14

No

73

32

105